OncoSec Medical IncOver The Counter Market:ONCSQ
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range
- 52 Week Range
- Volume8,001
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ONCSQ |
|---|---|---|
| 12:42 ET | 5000 | 1E-06 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
OncoSec Medical Inc | 10.0 | 0.0x | --- |
Pathfinder Cell Therapy Inc | 670.0 | 0.0x | --- |
IR BioSciences Holdings Inc | 20.0 | 0.0x | --- |
Adhera Therapeutics Inc | 17.3K | 0.0x | --- |
Anthera Pharmaceuticals Inc | 30.0 | 0.0x | --- |
Sienna Biopharmaceuticals Inc | 30.0 | 0.0x | --- |
Company Information
OncoSec Medical Incorporated is a late-stage immuno-oncology company. The Company is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its core technology, ImmunoPulse, is a drug-device therapeutic modality platform comprised of an OncoSec Medical System EP device (the OMS EP Device) and a DNA plasmid delivery and application method that enables transient expression of recombinant therapeutic molecules in cells. The OMS EP Device is designed to promote cellular uptake of plasmid DNA injected directly into solid tumors to allow subsequent expression of the encoded therapeutic protein. The OMS EP Device can be adapted to treat different tumor types and consists of an electrical pulse generator and a disposable applicator. Its lead product candidate, tavokinogene telseplasmid (TAVO), is a plasmid encoding human interleukin-12.
Contact Information
- Headquarters
- 820 Bear Tavern RoadEWING, NJ, United States 08628
- Phone
- 858-210-7333
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.00 |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 6.0M |
OncoSec Medical Inc does not pay a dividend. | |
Beta | --- |
EPS | $-15.24 |
Book Value | $3.42 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
